Answer
Liver injury and hepatic failure, some requiring liver transplantation, have been reported with Esmya (ulipristal acetate) during post-marketing use.
Sources for this answer
- Esmya 5 mg Tablets (ulipristal acetate)Gedeon Richter (UK) Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 13Document updated
Sources checked